Geoffrey Risley, MD
Vascular Surgery · Pensacola, FLNPI 1578565735
Payments from drug & device makers
What this record shows
This record is dominated by other: $71,167 of the $96,198 with a category attached, or 74.0%. Angiodynamics, Inc. accounts for 76.3% of it on its own, with 22 other manufacturers making up the rest. Among vascular surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 375 payments — averaging $256.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$73K
- W. L. Gore & Associates, Inc.$7K
- Endologix LLC$6K
- Medtronic$4K
- Penumbra, Inc.$2K
- Bolton Medical Inc$808
- plus $3K from 17 others
Across 8 payments — averaging $1263.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endologix LLC$10K
What the payments were for
- Travel & lodging$2,5623%
- Food & beverage$22,46923%
- Other$71,16774%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 49 | $73,413 |
| W. L. Gore & Associates, Inc. | 82 | $7,477 |
| Endologix LLC | 29 | $5,625 |
| Medtronic(2 entities) | 91 | $3,701 |
| Penumbra, Inc. | 38 | $1,682 |
| Bolton Medical Inc | 9 | $808 |
| Silk Road Medical, Inc. | 14 | $779 |
| Inari Medical, Inc. | 8 | $606 |
| Stryker | 12 | $462 |
| Veryan Medical Incorporated | 3 | $330 |
| Bard Peripheral Vascular, Inc. | 4 | $272 |
| Boston Scientific | 6 | $176 |
| Venclose Inc. | 4 | $154 |
| Abbott | 2 | $153 |
| Pfizer | 3 | $146 |
| Lemaitre Vascular, Inc. | 6 | $101 |
| Johnson & Johnson(2 entities) | 5 | $73 |
| Osiris Therapeutics Inc. | 1 | $61 |
| Davol Inc. | 2 | $57 |
| Organogenesis Inc. | 2 | $47 |
| Philips North America LLC | 2 | $35 |
| Cook Medical LLC | 2 | $27 |
| Cardiovascular Systems Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$72,142
- Ovation$1,865
- Alto Abdominal Stent Graft System$1,611
- Ellipsys$1,549
- VIABAHN Endoprosthesis$1,473
- GORE VIABAHN VBX Balloon Expandable Endo$1,276
- AFX$1,030
- Indigo System$884
- VIABAHN VBX Balloon Expandable Endoprosthesis$738
- ENDOCROSS Device$650
- Torus Stent Graft System$650
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$549
- FLOWTRIEVER CATHETER, S$482
- CT THROMBECTOMY SYSTEM KIT$482
- ENROUTE Transcarotid Neuroprotection System$474
- ENROUTE Transcarotid Stent$474
- Relay Grafts$347
- EXCLUDER AAA Endoprosthesis$311
- ENROUTE .014 Guidewire$275
- ENHANCE Transcarotid Peripheral Access Kit$275
How this compares
$96,198 in reported general payments places this provider in the 95th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $7,607 |
| Cilostazol | 91 | $1,466 |
| ClopidogrelClopidogrel Bisulfate | 109 | $1,344 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $247 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $146 | $7,60713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 385 vascular surgery providers in Florida.
Other vascular surgery in Pensacola
- James LonquistPensacola$45K
- Christopher LecroyPensacola$35K
- Huey McDanielPensacola$35K
- Samuel TapperStuart$1.3M
- Mariano ArosemenaBradenton$472K
- Manuel Perez IzquierdoOrlando$302K
- Erin MooreJacksonville$300K
- Rajesh MalikNaples$237K
- Charles BaileyTampa$162K
- Joseph WasselleMelbourne$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.